PropertyValue
is ?:annotates of
?:authorAffiliation
  • []
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15585/mmwr.mm7111e1
?:hasPublicationType
?:journal
  • MMWR. Morbidity and mortality weekly report
is ?:pmid of
?:pmid
?:pmid
  • 35298453
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.323
?:rankingScore_hIndex
  • 176
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all